DeepSeek's Price Hike Is the Real Comp. Its 75x Multiple Is Not.
One unaudited revenue print removes the cost assumption behind most app-layer margin models, while the headline valuation should stay out of your comp set entirely.
The contradiction in the coverage
The same news cycle tells two opposite stories about DeepSeek. The Information's dealmaking coverage still casts it as the price-pressure player: open-source models and price cuts are keeping AI costs in check, and DeepSeek's low-cost scale adds to that pressure. The Information's own reporting on the raise says something different. Revenue more than doubled partly because DeepSeek raised prices. Both can't be the right lens for your cost models. The pricing behavior is the harder evidence, because a company can inflate a revenue number far more easily than it can fake demand holding up after a price increase.
Treat the revenue figure with care. It is an unaudited, CEO-supplied annualized run-rate, disclosed at a private investor meeting and leaked during an active raise. The size of the price hike was not disclosed. Rely on the direction of the move, not the magnitude.
Who takes the tier DeepSeek left
A price increase from the cost leader leaves room underneath it. AINews data shows who is moving into that room. Xiaomi's MIT-licensed MiMo-V2.6-Pro scores 46 on the AA index against GPT-5.6 Sol's 47, at $0.13 versus $1.99 per task. In practice, the ultra-low-cost position is moving from one Chinese lab to an open-weight release from another. For sourcing, the low-cost tier is not closing. It is being taken over by open weights, which favors serving-efficiency and routing companies over any single model vendor.
Why the 75x doesn't transfer
The deal terms reported by The Information are 50B yuan ($7.5B) at 500B yuan (~$75B), roughly 10% dilution, a targeted end-October close, and a Shanghai Stock Exchange listing path. The Information Briefing notes DeepSeek is raising cash equal to 7.5x its revenue run-rate. Three features make the multiple specific to DeepSeek:
- Captive capital. The buyers are domestic, and the listing venue has no Western institutional access.
- A restricted TAM. Choosing Shanghai confirms continued exclusion from US and EU regulated enterprise buyers.
- A thin reprice cushion. At ~10% dilution, there is little room to adjust if the close slips.
Founders will still bring this number to your next negotiation. The committee note should come first.
The comp worth importing from DeepSeek is its pricing behavior, not its valuation multiple.
The disclosure event ahead
A Shanghai listing would make DeepSeek plausibly the first frontier lab with audited public financials. The Information notes that Anthropic's IPO timing leaves Wall Street without a Western comparable. Audited gross margins and capex intensity will either support private AI marks across the sector or put them under pressure. Your markdown policy should be agreed before that happens.
The smart move
Model AI monetization and AI cost deflation as two separate variables. Most sector models still assume they move together. Then stress-test the holdings whose path to software-like gross margins depends on per-token costs falling.
What to do
Commission a gross-margin bridge from every AI-exposed portfolio company this week, including a scenario where model input costs rise 20% and stay there. Flag any company that drops below 60% gross margin.
Circulate a one-page valuation-committee note before the next AI-app negotiation explaining why DeepSeek's ~75x run-rate multiple is non-transferable: captive domestic capital, a Shanghai bid, and a restricted Western TAM.
Set a monitoring trigger on DeepSeek's targeted end-October close and any Shanghai filing, and record whether the round lands at 500B yuan or reprices.